Literature DB >> 7524373

Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.

L Kopala, W G Honer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7524373     DOI： 10.1176/ajp.151.11.1714a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

Review 1.  The Canadian experience with risperidone for the treatment of schizophrenia: an overview.

Authors:  M Iskedjian; M Hux; G J Remington
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 2.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 3.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.

Authors:  P Tibbo; L Warneke
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

5.  Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study.

Authors:  Haluk A Savas; Mehmet Yumru; Murat E Ozen
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

6.  A cholinergic hypothesis of the unconscious in affective disorders.

Authors:  Costa Vakalopoulos
Journal:  Front Neurosci       Date:  2013-11-22       Impact factor: 4.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.